Latest Venous thrombosis Stories
A new technique that combines the heat and energy of ultrasound with highly targeted delivery of clot-busting drugs appears to be an effective treatment for patients with acute massive pulmonary embolism (PE), commonly referred to as a blood clot in the lung, was presented today at the 37th Annual VEITHsymposium (Vascular Surgery) in New York by Dr. Peter Lin of Baylor College of Medicine in Texas. The novel treatment is called ultrasound-accelerated catheter-directed thrombolysis...
Patients undergoing plastic/reconstructive surgeries benefit from individual blood clot risk assessmentsPatients undergoing plastic or reconstructive surgery should receive a risk assessment before their procedure to predict whether they'll develop potentially fatal blood clots in the legs or lungs, according to research at the University of Michigan Medical School. Researchers also found that 1 in 9 patients at highest risk based on that assessment will develop clots if not given...
PEACHTREE CITY, Ga., Nov. 10, 2010 /PRNewswire/ -- SIGVARIS, the global leader in medical compression therapy, has teamed up with the North American Thrombosis Forum and Boston Red Sox Manager and blood clot survivor, Terry Francona, to raise awareness about the dangers of blood clots. Did you know that every year more people die from blood clots than from breast cancer, AIDS and car accidents combined? That's why SIGVARIS, the global leader in medical compression stockings and socks, is...
New study identifies risk factors for the complications of a dangerous blood clotRisk factors for venous thromboembolism after total hip replacement (THR) surgery were identified in a new study published in the September 2010 issue of The Journal of Bone and Joint Surgery (JBJS). While the rate of thromboembolism has been significantly reduced through medication, understanding the risk factors could further reduce the likelihood of patients developing this potentially fatal...
New study identifies risk factors for the complications of a dangerous blood clot ROSEMONT, Ill., Sept. 16 /PRNewswire-USNewswire/ -- Risk factors for venous thromboembolism after total hip replacement (THR) surgery were identified in a new study published in the September 2010 issue of The Journal of Bone and Joint Surgery (JBJS). While the rate of thromboembolism has been significantly reduced through medication, understanding the risk factors could further reduce the likelihood of...
Arming Healthcare Professionals to Stop the Clot® TARRYTOWN, N.Y., Sept. 14 /PRNewswire-USNewswire/ -- The National Blood Clot Alliance (NBCA) is making available an easily accessible, no-cost online curriculum for nurses, nurse practitioners, physician assistants, and pharmacists to help increase understanding about the diagnosis and treatment of blood clots and blood clotting disorders. Access to the curriculum, entitled Stop The Clot®: What Every Healthcare Professional Should...
(Ivanhoe Newswire) -- A new study suggests hospital screening methods for predicting a potentially life-threatening blood clot -- known as a pulmonary embolism -- in patients needing brain surgery are not up to par.A pulmonary embolism is one of the most severe complications of brain surgery. It happens when one or more arteries in the lungs become blocked. In most cases, a pulmonary embolism is caused by blood clots that travel to the lungs from other parts of the body. A blood clot in the...
TORONTO, Aug. 25 /PRNewswire/ -- Millennium Research Group (MRG), the global authority on medical technology market intelligence, finds that although venous procedures are set to grow by more than 10% through 2013, a lack of awareness among referring physicians is a major roadblock in increased interventions in the venous system. Despite this trend, specialists are increasingly adopting new technologies, with 55% of respondents having used pharmacomechanical thrombectomy systems for deep...
NEW YORK, July 6, 2010 /PRNewswire/ -- The Steering Committee of the EXCLAIM study that explored the benefit of extended prophylaxis of venous thrombo embolism (VTE) with enoxaparin in acutely ill medical patients, announced today the publication of the comprehensive study results in the peer-reviewed journal Annals of Internal Medicine. To view the Multimedia News Release, please click: http://multivu.prnewswire.com/mnr/prne/exclaim/44182/ The study showed that in...
BASKING RIDGE, N.J., June 8 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David J. Mazzo, PhD, President and CEO, will be presenting at the Jefferies 2010 Global Life Sciences Conference in New York City held June 8-11, 2010. At this invitation-only event, Dr. Mazzo's presentation will be given at 1:15 pm (EDT) on Friday, June 11 in Track E and will include an overview of the...
